Skip to main content
Equibles
SHC logo

SHC · Sotera Health Co · Metrics

Track SHC — free

Use SHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.93 +0.29 (+1.64%) At close · Oct 20
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.03B
Shares
285.37M
Volume · Oct 20 1.8M Avg daily vol (3M) 2.39M

SHC metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.93
Market cap
$5.03B

Price action

20 metrics
Price change (1W)
-1.5%
Price change (30D)
-4.1%
Price change (3M)
+3.0%
Price change (6M)
+12.3%
Price change (YTD)
+1.6%
Price change (1Y)
+7.3%
Trailing year
Price change (5Y)
-30.8%
52-week high
$19.57
52-week low
$13.13
Change from 52-week high
-8.4%
Change from 52-week low
+36.6%
Annualized volatility
28.5%
Annualized volatility (3M)
23.4%
Beta
1.0
RSI (14D)
45.1
Price vs SMA 50
-3.7%
Price vs SMA 200
+5.3%
Avg volume (3M)
2.39M
Relative volume
0.8
Average dollar volume
$44.08M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
285.37M

Valuation

12 metrics
P / E (TTM)
31.5
Trailing earnings · reciprocal yield 3.2%
PEG ratio
0.1
EV / revenue
5.6×
reciprocal yield 17.8%
EV / EBITDA
—
EV / EBIT
23.5×
reciprocal yield 4.3%
P / sales
4.1×
reciprocal yield 24.2%
P / book
7.6
reciprocal yield 13.2%
FCF yield
2.2%
TTM · current market cap
Buyback yield
—
P / FCF
44.7
reciprocal yield 2.2%
P / operating cash flow
17.2
reciprocal yield 5.8%
Earnings yield
3.2%

Historical valuation

8 metrics
P / E historical average (3Y)
81.6×
reciprocal yield 1.2%
P / E historical average (5Y)
70.0×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
5.4×
reciprocal yield 18.4%
EV / revenue historical average (5Y)
5.9×
reciprocal yield 17.1%
EV / EBIT historical average (3Y)
22.1×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
22.7×
reciprocal yield 4.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
55.0%
Operating margin
—
Trailing 12 months
Net margin
13.4%
Gross profit (TTM)
$668.51M
Operating profit (TTM)
$297.63M
Net income (TTM)
$163.48M
Trailing 12 months
Diluted EPS (TTM)
$0.57
FCF margin
9.3%
Effective tax rate
38.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$4.22
Gross profit per diluted share (TTM)
$2.32
Operating profit per diluted share (TTM)
$1.04
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.57
Operating cash flow per diluted share (TTM)
$1.01
Free cash flow per diluted share (TTM)
$0.39
Capital expenditures per diluted share (TTM)
$0.62
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.13
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.2%
Year over year
Net income growth YoY
+573.7%
Revenue (TTM)
$1.22B
Trailing 12 months
EPS growth YoY
+533.3%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+5.1%
Revenue CAGR (5Y)
+7.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+16.0%
FCF CAGR (5Y)
+17.3%

Quality

14 metrics
Return on equity
24.6%
Return on assets
4.9%
Debt / equity
3.2
Current ratio
2.8
EBITDA (TTM)
—
Free cash flow (TTM)
$112.70M
Quick ratio
2.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.78B
Latest balance sheet
Cash & equivalents
$356.72M
Total assets
$3.31B
Total debt
$2.14B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$292.19M
Capital expenditures (TTM)
$179.49M
R&D (TTM)
—
SG&A (TTM)
$257.18M
Stock compensation (TTM)
$37.13M
R&D / revenue
—
Stock compensation / revenue
3.1%

Ownership (13F)

9 metrics
13F filers
320
13F filer change QoQ
+21
Institutional ownership
103.3%
Conviction holders (share of 13F filers)
4.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+13.3%
Holder tenure
10.0
Price vs estimated holder cost
+11.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.8%

Short interest

3 metrics
Short interest
5.2%
Latest settlement · 6.8 days to cover
Days to cover
6.8d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$24.00M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 32 filings 32 filers Visit website Investor relations